Abstract
DOPAMINE receptors are classified into Dl and D2 subtypes on the basis of their pharmacological properties and the intracellular responses they mediate1. The cerebral D2 dopamine receptor is the target of drugs used to alleviate the main symptoms of schizophrenia2–4. Although it is considered to be a single molecular entity, there is evidence that multiple D2-receptor subtypes exist5,6. A complementary DNA encoding a D2 receptor has recently been cloned7 and the deduced 415-amino-acid sequence indicates that it belongs to the large superfamily of receptors coupled to G proteins, and that its topology consists of seven transmembrane domains. In this family, the genes are frequently without introns and each is believed to encode a unique polypeptide product. Here we show that the gene for the D2 receptor produces two receptor isoforms by alternative messenger RNA splicing, providing a route to receptor diversity in this family. One isoform corresponds to the D2(415) receptor7, but the second contains an additional sequence encoding a 29-amino-acid fragment, defining a novel D2(444) receptor isoform. Expression of the two isoforms is tissue-specific, and both are regulated by guanyl nucleotides. As the extra sequence is located within a putative cytoplasmic loop that binds to G proteins, the two isoforms might interact with different G proteins and thereby initiate distinct intracellular signals.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kebabian, J. W. & Calne, D. B. Nature 277, 93–96 (1979).
Carlsson, A. & Lindqvist, M. Acta Pharmac. Toxicol. 20, 140–144 (1963).
Creese, I., Burt, D. R. & Snyder, S. H. Science 192, 481–483 (1976).
Seeman, P. Pharmacol. Rev. 32, 229–313 (1980).
Sokoloff, P., Martres, M. P. & Schwartz, J. C. Nature 288, 283–286 (1980).
Schwartz, J. C. et al. in Catecholamines: Neuropharmacology and Central Nervous System. Theoretical Aspects (eds Usdin, E., Carlsson, A., Dahlström, A. & Engel, J.) 59–72 (Liss, New York, 1984).
Bunzow, J. R. et al. Nature 336, 783–787 (1988).
Shapiro, M. B. & Senapathy, P. Nucleic Acids Res. 15, 7155–7174 (1987).
Martres, M. P., Bouthenet, M. L., Salès, N., Sokoloff, P., & Schwartz, J. C. Science 228, 752–755 (1985).
Salès, N., Martres, M. P., Bouthenet, M. L. & Schwartz, J. C. Neuroscience 28, 673–700 (1989).
Saiki, R. K. et al. Science 239, 487–491 (1988).
Doherty, P. J., Huesca-Contreras, M., Dosch, H. M. & Pan, S. Analyt. Biochem. 177, 7–10 (1989).
Dixon, R. A. F. et al. Nature 326, 73–77 (1987).
Kubo T. et al. FEBS Lett. 241, 119–125 (1988).
Rubenstein, R. C., Wong, S. K. F. & Ross, E. M. J. biol. Chem. 262, 16655–16662 (1987).
Bray, P. et al. Proc. natn. Acad. Sci. U.S.A. 83, 8893–8897 (1986).
Andreadis, A., Gallego, M. E. & Nadal-Ginard, B. A. Rev. cell. Biol. 3, 207–242 (1987).
Owen, F. et al. Lancet ii, 223–226 (1978).
Seeman, P. et al. Science 225, 728–731 (1984).
Huynh, T. V., Young, R. A. & Davis, R. W. in DNA Cloning. A Practical Approach Vol.1 (ed. Glover, D. M.) 49–78 (IRL, Oxford, 1985).
Gubler, U. & Hoffman, B. J. Gene 25, 263–269 (1983).
Chirgwin, J. J., Przbyla, A. E., MacDonald, R. J. & Rutter, W. J. Biochemistry 18, 5294–5299 (1979).
Aviv, H. & Leder, P. Proc. natn. Acad. Sci. U.S.A. 69, 1408–1412 (1972).
Sanger, F., Nicklen, S. & Coulson, A. R. Proc. natn. Acad. Sci. U.S.A. 74, 5463–5467 (1977).
Sokoloff, P., Martres, M. P., Delandre, M., Redouane, K. & Schwartz, J. C. Naunyn-Schmiedebergs Archs Pharmak. 327, 221–227 (1984).
Graham, F. L. & Van der Eb, A. J. Virology 52, 456–467 (1973).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Giros, B., Sokoloff, P., Martres, MP. et al. Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature 342, 923–926 (1989). https://doi.org/10.1038/342923a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/342923a0
This article is cited by
-
The human neuropsychiatric risk gene Drd2 is necessary for social functioning across evolutionary distant species
Molecular Psychiatry (2023)
-
Investigating the ligand agonism and antagonism at the D2long receptor by dynamic mass redistribution
Scientific Reports (2022)
-
The dopaminergic control of Cushing’s syndrome
Journal of Endocrinological Investigation (2022)
-
Allosteric modulation of dopamine D2L receptor in complex with Gi1 and Gi2 proteins: the effect of subtle structural and stereochemical ligand modifications
Pharmacological Reports (2022)
-
New Antipsychotic Medications in the Last Decade
Current Psychiatry Reports (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.